COFCO Biotechnology Co., Ltd.

Symbol: 000930.SZ

SHZ

6.57

CNY

Market price today

  • -21.1266

    P/E Ratio

  • -2.7465

    PEG Ratio

  • 12.13B

    MRK Cap

  • 0.09%

    DIV Yield

COFCO Biotechnology Co., Ltd. (000930-SZ) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.06%

Operating Profit Margin

-0.03%

Net Profit Margin

-0.03%

Return on Assets

-0.03%

Return on Equity

-0.05%

Return on Capital Employed

-0.05%

Company general description and statistics

Sector: Basic Materials
Industry: Chemicals - Specialty
CEO:Mr. De Guo Zhang
Full-time employees:7642
City:Bengbu
Address:No. 1, Zhongliang Avenue
IPO:1999-07-12
CIK:

COFCO Biotechnology Co., Ltd. engages in the processing and production of agricultural products in China. The company offers edible corn, special, waxy corn, and modified waxy corn starch; Feed ingredients, such as corn gluten meal, sprayed corn husk, corn germ meal, DDGS, fertilizer raw materials and glutamic acid residue; fructose and functional sugar alcohol; fuel ethanol and edible alcohol; and monosodium glutamate, citric acid, potassium citrate, polylactic acid, phytosterols, and natural vitamin E. It also offers corn crude oil, edible liquid carbon dioxide, corn fiber feed, bacterial protein, microorganisms, compound antioxidant, nutritious health food; fructose, maltose, glucose, oligomeric isomalt, and beer syrups; plastic woven bags, plastic barrels, container bags and other plastic packaging products, valve-mouth paper bags, and other paper packaging products; liquors; and corn germ, rapeseed, peanut, soybean, and other edible oils, as well as warehousing and logistics, and information consulting services. In addition, the company is also involved in the research and development of biological engineering; production and sales of amino acids, compound fertilizers, and organic fertilizers; sales of chemical products and grains; wholesale and retail of edible agricultural products; export of products and related technologies of the company; import and export of raw and auxiliary materials, instruments and meters, mechanical equipment, and related technologies required for production; production and sales of steam; wholesale of coal; production, management, and sale of food and food additives; house leasing; food purchase; power generation; provision of pre-packaged food and bulk food, and dairy products; and wholesale and retail activity. The company was formerly known as COFCO Biochemical (Anhui) Co., Ltd. and changed its name to COFCO Biotechnology Co., Ltd. in September 2019. COFCO Biotechnology Co., Ltd. was founded in 1998 and is based in Bengbu, China.

General Outlook

When we look at how much money they make before expenses, they keep 0.056% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.025%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.028%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.032% return, is a testament to COFCO Biotechnology Co., Ltd.'s adeptness in optimizing resource deployment. COFCO Biotechnology Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.055%. Furthermore, the proficiency of COFCO Biotechnology Co., Ltd. in capital utilization is underscored by a remarkable -0.045% return on capital employed.

Stock Prices

COFCO Biotechnology Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $6, while its low point bottomed out at $5.74. This variance in figures offers investors a lucid insight into the roller-coaster ride that is COFCO Biotechnology Co., Ltd.'s stock market.

Liquidity Ratios

Analyzing 000930.SZ liquidity ratios reveals its financial health of the firm. The current ratio of 113.24% gauges short-term asset coverage for liabilities. The quick ratio (34.12%) assesses immediate liquidity, while the cash ratio (18.83%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio113.24%
Quick Ratio34.12%
Cash Ratio18.83%

Profitability Ratios

000930.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -2.52% underscores its earnings before tax deductions. The effective tax rate stands at -15.03%, revealing its tax efficiency. The net income per EBT, 111.75%, and the EBT per EBIT, 100.57%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -2.50%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-2.52%
Effective Tax Rate-15.03%
Net Income per EBT111.75%
EBT per EBIT100.57%
EBIT per Revenue-2.50%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.13, it details the span from stock purchase to revenue.

cards.indicatorcards.value
Days of Sales Outstanding34
Days of Inventory Outstanding64
Operating Cycle82.22
Days of Payables Outstanding13
Cash Conversion Cycle69
Receivables Turnover19.97
Payables Turnover28.03
Inventory Turnover5.71
Fixed Asset Turnover2.41
Asset Turnover1.14

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 1.71, and free cash flow per share, 1.43, depict cash generation on a per-share basis. The cash per share value, 0.68, showcases liquidity position. A payout ratio of -2.02 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.15, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share1.71
Free Cash Flow per Share1.43
Cash per Share0.68
Payout Ratio-2.02
Operating Cash Flow Sales Ratio0.15
Free Cash Flow to Operating Cash Flow Ratio0.83
Cash Flow Coverage Ratio0.63
Short Term Coverage Ratio0.65
Capital Expenditure Coverage Ratio5.95
Dividend Paid and Capex Coverage Ratio1.87
Dividend Payout Ratio0.09

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 27.93%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.48, we discern the balance between debt and equity financing. The long-term debt to capitalization, 1.11%, and total debt to capitalization, 32.61%, ratios shed light on its capital structure. An interest coverage of -4.82 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio27.93%
Debt Equity Ratio0.48
Long Term Debt to Capitalization1.11%
Total Debt to Capitalization32.61%
Interest Coverage-4.82
Cash Flow to Debt Ratio0.63
Company Equity Multiplier1.73

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 11.02, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.33, reflects the portion of profit attributed to each share. The book value per share, 5.68, represents the net asset value distributed per share, while the tangible book value per share, 5.41, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share11.02
Net Income Per Share-0.33
Book Value Per Share5.68
Tangible Book Value Per Share5.41
Shareholders Equity Per Share5.68
Interest Debt Per Share2.00
Capex Per Share-0.34

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 1.87%, indicates top-line expansion, while the gross profit growth, -57.88%, reveals profitability trends. EBIT growth, -133.73%, and operating income growth, -133.73%, offer insights into operational profitability progression. The net income growth, -156.84%, showcases bottom-line expansion, and the EPS growth, -157.89%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth1.87%
Gross Profit Growth-57.88%
EBIT Growth-133.73%
Operating Income Growth-133.73%
Net Income Growth-156.84%
EPS Growth-157.89%
EPS Diluted Growth-157.89%
Weighted Average Shares Growth-1.27%
Weighted Average Shares Diluted Growth-1.27%
Dividends per Share Growth114.04%
Operating Cash Flow Growth177.15%
Free Cash Flow Growth831.54%
10-Year Revenue Growth per Share43.65%
5-Year Revenue Growth per Share14.99%
3-Year Revenue Growth per Share2.25%
10-Year Operating CF Growth per Share38.31%
5-Year Operating CF Growth per Share313.36%
3-Year Operating CF Growth per Share167.68%
10-Year Net Income Growth per Share-716.42%
5-Year Net Income Growth per Share-224.96%
3-Year Net Income Growth per Share-201.77%
10-Year Shareholders Equity Growth per Share89.09%
5-Year Shareholders Equity Growth per Share13.66%
3-Year Shareholders Equity Growth per Share0.89%
10-Year Dividend per Share Growth per Share235.16%
5-Year Dividend per Share Growth per Share514.11%
3-Year Dividend per Share Growth per Share615.64%
Receivables Growth-40.59%
Inventory Growth-32.66%
Asset Growth-8.52%
Book Value per Share Growth-12.51%
Debt Growth16.59%
R&D Expense Growth21.88%
SGA Expenses Growth105.00%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 14,636,708,815.58, captures the company's total value, considering both debt and equity. Income quality, -3.26, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.01, gauges operational efficiency, while the research and development to revenue, 0.80%, highlights investment in innovation. The ratio of intangibles to total assets, 5.85%, indicates the value of non-physical assets, and capex to operating cash flow, -32.32%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value14,636,708,815.58
Income Quality-3.26
Sales General and Administrative to Revenue0.01
Research and Development to Revenue0.80%
Intangibles to Total Assets5.85%
Capex to Operating Cash Flow-32.32%
Capex to Revenue-3.13%
Capex to Depreciation-124.61%
Stock-Based Compensation to Revenue0.02%
Graham Number6.46
Return on Tangible Assets-3.86%
Graham Net Net-0.93
Working Capital893,510,471
Tangible Asset Value9,954,861,252
Net Current Asset Value401,035,474
Average Receivables2,079,093,959
Average Payables800,721,882
Average Inventory3,148,734,245.5
Days Sales Outstanding28
Days Payables Outstanding13
Days of Inventory On Hand48
ROIC-3.69%
ROE-0.06%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.17, and the price to book ratio, 1.17, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.59, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 4.60, and price to operating cash flows, 3.84, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.17
Price to Book Ratio1.17
Price to Sales Ratio0.59
Price Cash Flow Ratio3.84
Price Earnings to Growth Ratio-2.75
Enterprise Value Multiple56.82
Price Fair Value1.17
Price to Operating Cash Flow Ratio3.84
Price to Free Cash Flows Ratio4.60
Price to Tangible Book Ratio1.18
Enterprise Value to Sales0.72
Enterprise Value Over EBITDA272.17
EV to Operating Cash Flow7.45
Earnings Yield-4.87%
Free Cash Flow Yield10.75%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of COFCO Biotechnology Co., Ltd. (000930.SZ) on the SHZ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -21.127 in 2024.

What is the ticker symbol of COFCO Biotechnology Co., Ltd. stock?

The ticker symbol of COFCO Biotechnology Co., Ltd. stock is 000930.SZ.

What is company IPO date?

IPO date of COFCO Biotechnology Co., Ltd. is 1999-07-12.

What is company current share price?

Current share price is 6.570 CNY.

What is stock market cap today?

The market cap of stock today is 12132466776.000.

What is PEG ratio in 2024?

The current -2.746 is -2.746 in 2024.

What is the number of employees in 2024?

In 2024 the company has 7642.